E. Anders Kolb
- Hematology top 0.5%
- Acute Myeloid Leukemia Research 100
- Multiple Myeloma Research and Treatments 21
- Oncology top 1%
- CAR-T cell therapy research 21
- Cancer Research top 2%
- Neurology top 1%
- Neuroblastoma Research and Treatments 41
- Molecular Biology top 2%
- Protein Degradation and Inhibitors 30
- Cancer therapeutics and mechanisms 29
-
- Acute Lymphoblastic Leukemia research 37
-
- Sarcoma Diagnosis and Treatment 19
- Co-authors
- Richard GörlickPeter J. HoughtonMalcolm A. SmithJohn M. MarisStephen T. KeirC. Patrick ReynoldsRichard B. LockChristopher L. Morton
- Cited by
- HematologyOncologyCancer Research
- Journals
- Pediatric Blood & Cancer (86 papers)Blood (63 papers)Journal of Clinical Oncology (14 papers)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
E. Anders Kolb
270 papers receiving 6.2k citations
Peers
Comparison fields: 5 of 127
- Hematology 1.2k
- Oncology 1.8k
- Cancer Research 919
- Neurology 857
- Molecular Biology 3.1k
Countries citing papers authored by E. Anders Kolb
This map shows the geographic impact of E. Anders Kolb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Anders Kolb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Anders Kolb more than expected).
Fields of papers citing papers by E. Anders Kolb
This network shows the impact of papers produced by E. Anders Kolb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Anders Kolb. The network helps show where E. Anders Kolb may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E. Anders Kolb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 14 | |
| 6 | 2022 | 6 | |
| 7 | 2021 | 26 | |
| 8 | 2021 | 57 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 5 | |
| 11 | 2020 | 23 | |
| 12 | 2020 | 2 | |
| 13 | 2019 | 46 | |
| 14 | 2017 | 20 | |
| 15 | 2017 | 15 | |
| 16 | 2016 | 40 | |
| 17 | 2014 | 90 | |
| 18 | 2010 | 79 | |
| 19 | Pediatric preclinical testing program (PPTP) evaluation of the fully human anti-IGF-1R antibody SCH 717454 | 2007 | 1 |
| 20 | Reolysin®, an unmodified Reovirus, has significant anti-tumor activity in childhood sarcomas | 2006 | 5 |
About E. Anders Kolb
E. Anders Kolb is a scholar working on Hematology, Oncology, Neurology, Genetics and Cancer Research, having authored 283 papers that have together received 6.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (100 papers), Neuroblastoma Research and Treatments (41 papers), Acute Lymphoblastic Leukemia research (37 papers), Protein Degradation and Inhibitors (30 papers), Cancer therapeutics and mechanisms (29 papers), Multiple Myeloma Research and Treatments (21 papers), CAR-T cell therapy research (21 papers) and Sarcoma Diagnosis and Treatment (19 papers). The work is most often cited by research in Hematology (1.2k citations), Oncology (1.8k citations), Cancer Research (919 citations), Neurology (857 citations) and Molecular Biology (3.1k citations). E. Anders Kolb has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Richard Görlick, Peter J. Houghton, Malcolm A. Smith, John M. Maris, Stephen T. Keir, C. Patrick Reynolds, Richard B. Lock, Christopher L. Morton, Hernán Carol and Min H. Kang. Their work appears in journals such as Pediatric Blood & Cancer, Blood, Journal of Clinical Oncology, Cancer Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.